title: Oxidative damage to ferritin by 5-aminolevulinic acid.
abstract: 5-Aminolevulinic acid (ALA), a heme precursor overproduced in various porphyric disorders, has been implicated in iron-mediated oxidative damage to biomolecules and cell structures. From previous observations of ferritin iron release by ALA, we investigated the ability of ALA to cause oxidative damage to ferritin apoprotein. Incubation of horse spleen ferritin (HoSF) with ALA caused alterations in the ferritin circular dichroism spectrum (loss of a alpha-helix content) and altered electrophoretic behavior. Incubation of human liver, spleen, and heart ferritins with ALA substantially decreased antibody recognition (51, 60, and 28% for liver, spleen, and heart, respectively). Incubation of apoferritin with 1-10mM ALA produced dose-dependent decreases in tryptophan fluorescence (11-35% after 5h), and a partial depletion of protein thiols (18% after 24h) despite substantial removal of catalytic iron. The loss of tryptophan fluorescence was inhibited 35% by 50mM mannitol, suggesting participation of hydroxyl radicals. The damage to apoferritin had no effect on ferroxidase activity, but produced a 61% decrease in iron uptake ability. The results suggest a local autocatalytic interaction among ALA, ferritin, and oxygen, catalyzed by endogenous iron and phosphate, that causes site-specific damage to the ferritin protein and impaired iron sequestration. These data together with previous findings that ALA overload causes iron mobilization in brain and liver of rats may help explain organ-specific toxicities and carcinogenicity of ALA in experimental animals and patients with porphyria.
authors.affiliation: Departamento de Bioqui;mica, Instituto de Qui;mica, Universidade de São Paulo, Av. Prof. Lineu Prestes 748, CEP 05508-900, São Paulo, SP, Brazil.
authors.forename: Maria E M
authors.initials: ME
authors.lastname: Rocha
authors.forename: Fernando
authors.initials: F
authors.lastname: Dutra
authors.forename: Brian
authors.initials: B
authors.lastname: Bandy
authors.forename: Regina L
authors.initials: RL
authors.lastname: Baldini
authors.forename: Suely L
authors.initials: SL
authors.lastname: Gomes
authors.forename: Adelaide
authors.initials: A
authors.lastname: Faljoni-Alário
authors.forename: Cleber W
authors.initials: CW
authors.lastname: Liria
authors.forename: M Terêsa M
authors.initials: MT
authors.lastname: Miranda
authors.forename: Etelvino J H
authors.initials: EJ
authors.lastname: Bechara
mesh_terms: D000622:Aminolevulinic Acid / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001052:Apoferritins / Q000737:chemistry / Q000187:drug effects; D002942:Circular Dichroism; D004305:Dose-Response Relationship, Drug; D015180:Electrophoresis, Gel, Two-Dimensional; D005293:Ferritins / Q000737:chemistry / Q000187:drug effects*; D006736:Horses; D006801:Humans; D066298:In Vitro Techniques; D007501:Iron / Q000378:metabolism; D008099:Liver / Q000737:chemistry; D008353:Mannitol / Q000494:pharmacology; D009206:Myocardium / Q000737:chemistry; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D010100:Oxygen / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D013154:Spleen / Q000737:chemistry; D013438:Sulfhydryl Compounds / Q000032:analysis; D013481:Superoxides / Q000378:metabolism; D014364:Tryptophan / Q000187:drug effects
chemical_list: D013438:Sulfhydryl Compounds; D013481:Superoxides; D008353:Mannitol; D000622:Aminolevulinic Acid; D014364:Tryptophan; D005293:Ferritins; D001052:Apoferritins; D007501:Iron; D010100:Oxygen